Alzheimer Disease

94 treatments and conditions followed through the public trial records. Not medical advice.How a status is set

Lists this condition and the narrower ones beneath it. A condition is not a diagnosis.

Treatments and conditions

Alzheimer Disease
Treatment and conditionWhere it standsTrials
[F-18]Flornaptitril for alzheimer diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
40 Hz sound stimulation for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
40 Hz Synchronous Audio-Visual Stimulation for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
AADvac1 for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
AD04 for alzheimer diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
AD5-NCOV for alzheimer diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)3
Administer Leqemi 10 mg/kg, every two weeks. for alzheimer diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Aducanumab for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)4
ATTN201 Focused Ultrasound to the CMN for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Atuzaginstat for alzheimer diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Audiovisual stimulation VR system for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
BBB opening for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Blood Brain Barrier (BBB) Disruption for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)2
Buntanetap for alzheimer diseasePhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Buntanetap tartrate for alzheimer diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)3
Cervical Lymphatic Microsurgery for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Cervical Lymphaticovenous and Lymph Node-to-Vein Anastomosis for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Combined metabolic activators for alzheimer diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Communication Bridge™ for alzheimer diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
DC-LVA treatment plus usual care for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Deep Brain Stimulation, DBS for alzheimer diseasePhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Deep cervical lymph node to venous bypass (DCLNV-BP) for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Deep cervical lymphatic-venous anastomosis for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Deep cervical lymphatic-venous anastomosis, LVA for alzheimer diseasePhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Deep Cervical Lymphaticovenous Anastomosis(DLVA) for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Deep Cervical lymphatlc-Venous Anastomosis Surgery for alzheimer diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Deep cervical lymphovenous anastomosis (LVA) for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Deep Cervical Lymphovenous Anastomosis + Routine Treatment for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Device-only fitting for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Donanemab for alzheimer diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)10
Donanemab + 2-Pyrazinecarboxamide, N-[3-[(4aR,7aS)-2-amino-6-(5-fluoro-2-pyrimidinyl)-4a,5,6,7-tetrahydropyrrolo[3,4-d][1,3]thiazin-7a(4H)-yl]-4-fluorophenyl]-5-methoxy- for alzheimer diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Donanemab + Dexamethasone for alzheimer diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Donanemab + Nivegacetor for alzheimer diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Emestedastat for alzheimer diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Etanercept for alzheimer diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
ExAblate 4000 Type 2.1 for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Exablate Model 4000 Type 2 + ADUCANUMAB + LECANEMAB for alzheimer diseasePhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Facilitate tDCS + CR for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Fasudil for alzheimer diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
FLUOROETHOXYBENZOVESAMICOL F-18 for alzheimer diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Focused Transcranial Ultrasound for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Gam-COVID-Vac for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
GammaSense Stimulation device for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Gantenerumab for alzheimer diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)3
GENUS device (Active Settings) for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
GV-971 for alzheimer diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)4
GV-971 + MEMANTINE for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
human Mesenchymal Stem Cells for alzheimer diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
intermittent theta burst stimulation (iTBS) for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
intermittent theta burst stimulation (iTBS) + METHYLPHENIDATE HYDROCHLORIDE for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
JNJ-64042056 for alzheimer diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Lecanemab for alzheimer diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)6
LECANEMAB + Etalanetug for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
low intensity focused ultrasound (LIFU) for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
LY-2599666 for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
LY3002813 for alzheimer diseasePhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
LY3002813-IV for alzheimer diseasePhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
LY3002813-SC for alzheimer diseasePhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Magnetic Resonance Imaging (MRI) with or without gadolinium contrast agents + Neuronavigation-guided single-element focused ultrasound transducer + Positron Emission Tomography (PET) + FLORBETAPIR F-18 + PERFLUTREN for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Matching Placebo (E2814) + LECANEMAB for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Memantine for alzheimer diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)2
Mevidalen for alzheimer diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
MK-1167 for alzheimer diseasePhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)2
Modified deep cervical Lymphatic-Venous Anastomosis for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
MR guided low intensity focused ultrasound for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
NanoLithium® NP03 for alzheimer diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Nicotinamide Riboside (NR) for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Nivegacetor for alzheimer diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
NMS-01 for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Obicetrapib 10 mg for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Placebo for alzheimer diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Placebo + ADUCANUMAB for alzheimer diseasePhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)4
Placebo + Donanemab for alzheimer diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Receive tDCS+CR for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Recombinant varicella zoster virus glycoprotein e antigen for alzheimer diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
REPAIR Sleep for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Semagludtide for alzheimer diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Service-only Fitting for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Simufilam for alzheimer diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)6
Sodium oligo-mannurarate 600mg for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Sodium oligo-mannurarate 900mg for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Sodium Oligomannate Capsules for alzheimer diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Solanezumab for alzheimer diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)7
Supermicrosurgical Lymphaticovenular Anastomosis (LVA) for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
tACS combined with 40 Hz sound stimulation for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Transcranial alternating current stimulation for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
transcranial magnetic resonance guided focused ultrasound BBB disruption for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
tributyrin for alzheimer diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Troculeucel for alzheimer diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Trontinemab for alzheimer diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)3
Valacyclovir for alzheimer diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Valiltramiprosate for alzheimer diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Wujia Yizhi granules for alzheimer diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Xanomeline Enteric Capsule + Xanomeline/Trospium Chloride Capsule for alzheimer diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1